Report Detail
Global Age-Related Macular Degeneration (AMD) AI Screening System Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM4614317 |
- 02 September, 2024 |
- Global |
- 103 Pages |
- GIR (Global Info Research) |
- Service & Software
Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting retinal features. These algorithms are useful not only for assessing the integrity of retinal structures, but also for localizing and quantifying retinal fluids during follow-up.
According to our (Global Info Research) latest study, the global Age-Related Macular Degeneration (AMD) AI Screening System market size was valued at US$ 46.5 million in 2023 and is forecast to a readjusted size of USD 2985 million by 2030 with a CAGR of 79.9% during review period.
The age-related macular degeneration (AMD) market trends are shaping the growth of the market. For instance rise in the adoption of age-related macular degeneration drugs (AMD) among the geriatric population suffering from age-related macular degeneration (AMD) drives the growth of the age-related macular degeneration (AMD) market size. For instance, according to the 2022 factsheet of World Health Organization, by 2030, 1 in 6 people in the world is projected to be aged 60 years or over, indicating a potential increase in the age-related macular degeneration (AMD) market size.
This report is a detailed and comprehensive analysis for global Age-Related Macular Degeneration (AMD) AI Screening System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Age-Related Macular Degeneration (AMD) AI Screening System market size and forecasts, in consumption value ($ Million), 2019-2030
Global Age-Related Macular Degeneration (AMD) AI Screening System market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Age-Related Macular Degeneration (AMD) AI Screening System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Age-Related Macular Degeneration (AMD) AI Screening System market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Age-Related Macular Degeneration (AMD) AI Screening System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Age-Related Macular Degeneration (AMD) AI Screening System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Age-Related Macular Degeneration (AMD) AI Screening System market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Age-Related Macular Degeneration (AMD) AI Screening System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hardware
Software
Market segment by Application
Medical Institutions
Great Health Scene
Market segment by players, this report covers
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Age-Related Macular Degeneration (AMD) AI Screening System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Age-Related Macular Degeneration (AMD) AI Screening System, with revenue, gross margin, and global market share of Age-Related Macular Degeneration (AMD) AI Screening System from 2019 to 2024.
Chapter 3, the Age-Related Macular Degeneration (AMD) AI Screening System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Age-Related Macular Degeneration (AMD) AI Screening System market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Age-Related Macular Degeneration (AMD) AI Screening System.
Chapter 13, to describe Age-Related Macular Degeneration (AMD) AI Screening System research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Age-Related Macular Degeneration (AMD) AI Screening System by Type
- 1.3.1 Overview: Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Type in 2023
- 1.3.3 Hardware
- 1.3.4 Software
- 1.4 Global Age-Related Macular Degeneration (AMD) AI Screening System Market by Application
- 1.4.1 Overview: Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Medical Institutions
- 1.4.3 Great Health Scene
- 1.5 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size & Forecast
- 1.6 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast by Region
- 1.6.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region, (2019-2030)
- 1.6.3 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Prospect (2019-2030)
- 1.6.4 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Prospect (2019-2030)
- 1.6.6 South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Airdoc Technology
- 2.1.1 Airdoc Technology Details
- 2.1.2 Airdoc Technology Major Business
- 2.1.3 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.1.4 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Airdoc Technology Recent Developments and Future Plans
- 2.2 Digital Diagnostics
- 2.2.1 Digital Diagnostics Details
- 2.2.2 Digital Diagnostics Major Business
- 2.2.3 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.2.4 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Digital Diagnostics Recent Developments and Future Plans
- 2.3 Eyenuk
- 2.3.1 Eyenuk Details
- 2.3.2 Eyenuk Major Business
- 2.3.3 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.3.4 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Eyenuk Recent Developments and Future Plans
- 2.4 RetinaLyze System
- 2.4.1 RetinaLyze System Details
- 2.4.2 RetinaLyze System Major Business
- 2.4.3 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.4.4 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 RetinaLyze System Recent Developments and Future Plans
- 2.5 Optomed
- 2.5.1 Optomed Details
- 2.5.2 Optomed Major Business
- 2.5.3 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.5.4 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Optomed Recent Developments and Future Plans
- 2.6 Sibionics Technology
- 2.6.1 Sibionics Technology Details
- 2.6.2 Sibionics Technology Major Business
- 2.6.3 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.6.4 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Sibionics Technology Recent Developments and Future Plans
- 2.7 Aeye Health
- 2.7.1 Aeye Health Details
- 2.7.2 Aeye Health Major Business
- 2.7.3 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.7.4 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Aeye Health Recent Developments and Future Plans
- 2.8 VUNO
- 2.8.1 VUNO Details
- 2.8.2 VUNO Major Business
- 2.8.3 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.8.4 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 VUNO Recent Developments and Future Plans
- 2.9 Medimaging Integrated Solution
- 2.9.1 Medimaging Integrated Solution Details
- 2.9.2 Medimaging Integrated Solution Major Business
- 2.9.3 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.9.4 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Medimaging Integrated Solution Recent Developments and Future Plans
- 2.10 EyRIS (SELENA+)
- 2.10.1 EyRIS (SELENA+) Details
- 2.10.2 EyRIS (SELENA+) Major Business
- 2.10.3 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.10.4 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 EyRIS (SELENA+) Recent Developments and Future Plans
- 2.11 Vistel
- 2.11.1 Vistel Details
- 2.11.2 Vistel Major Business
- 2.11.3 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.11.4 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Vistel Recent Developments and Future Plans
- 2.12 RETINA-AI Health
- 2.12.1 RETINA-AI Health Details
- 2.12.2 RETINA-AI Health Major Business
- 2.12.3 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.12.4 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.12.5 RETINA-AI Health Recent Developments and Future Plans
- 2.13 Acer Medical
- 2.13.1 Acer Medical Details
- 2.13.2 Acer Medical Major Business
- 2.13.3 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
- 2.13.4 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
- 2.13.5 Acer Medical Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Age-Related Macular Degeneration (AMD) AI Screening System by Company Revenue
- 3.2.2 Top 3 Age-Related Macular Degeneration (AMD) AI Screening System Players Market Share in 2023
- 3.2.3 Top 6 Age-Related Macular Degeneration (AMD) AI Screening System Players Market Share in 2023
- 3.3 Age-Related Macular Degeneration (AMD) AI Screening System Market: Overall Company Footprint Analysis
- 3.3.1 Age-Related Macular Degeneration (AMD) AI Screening System Market: Region Footprint
- 3.3.2 Age-Related Macular Degeneration (AMD) AI Screening System Market: Company Product Type Footprint
- 3.3.3 Age-Related Macular Degeneration (AMD) AI Screening System Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2030)
- 6.2 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2030)
- 6.3 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
- 6.3.1 North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2030)
- 6.3.2 United States Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 6.3.3 Canada Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2030)
- 7.2 Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2030)
- 7.3 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
- 7.3.1 Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2030)
- 7.3.2 Germany Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 7.3.3 France Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 7.3.5 Russia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 7.3.6 Italy Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region
- 8.3.1 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Region (2019-2030)
- 8.3.2 China Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 8.3.3 Japan Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 8.3.5 India Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 8.3.7 Australia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2030)
- 9.2 South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2030)
- 9.3 South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
- 9.3.1 South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
- 10.3.1 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
- 10.3.4 UAE Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Drivers
- 11.2 Age-Related Macular Degeneration (AMD) AI Screening System Market Restraints
- 11.3 Age-Related Macular Degeneration (AMD) AI Screening System Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Age-Related Macular Degeneration (AMD) AI Screening System Industry Chain
- 12.2 Age-Related Macular Degeneration (AMD) AI Screening System Upstream Analysis
- 12.3 Age-Related Macular Degeneration (AMD) AI Screening System Midstream Analysis
- 12.4 Age-Related Macular Degeneration (AMD) AI Screening System Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Age-Related Macular Degeneration (AMD) AI Screening System. Industry analysis & Market Report on Age-Related Macular Degeneration (AMD) AI Screening System is a syndicated market report, published as Global Age-Related Macular Degeneration (AMD) AI Screening System Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Age-Related Macular Degeneration (AMD) AI Screening System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
